Year
Edition number
№5 / 2025
ORIGINAL STUDIES
Kozlova I.V., Kudishina M.M., Bykova A.P., Uris D.D.
Laboratory and instrumental criteria and some mechanisms of osteopenic syndrome in case of inflammatory bowel diseases7-16
Bikbavova G.R., Livzan M.A., Lisyutenko N.S., Dranitsyn V.V., Mikhaleva L.V.
Cardiovascular risks in patients with ulcerative colitis: The role of assessing the markers of systemic inflammation and metabolic activity of intestinal microbiota17-25
Znakharenko E.A., Gerasimenko O.N., Maksimov V.N.
Clinical and molecular characteristics and peculiarities of nutritional status in non-alcoholic fatty liver disease26-35
Luzina E.V., Lazebnik L.B., Lareva N.V., Zhigula Z.M., Znamenshchikova S.Yu.
Results of Helicobacter pylori infection treatment in medical and non-medical workers in Trans- Baikal territory36-46
Tarasova L.V., Porfiryeva L.A., Dubova A.V., Kucherova N.Yu., Dimitrieva O.V.
Search for molecular markers in patients with familial hypercholesterolemia in Chuvash population47-56
Nikolenko E.S., Chulkov V.S., Syundyukova E.G., Sumerkina V.A., Pykhova L.R., Chulkov Vl.S.
Prognostic value of placental growth factor (PlGF) in “white-coat hypertension” in pregnant individuals57-64
Seleznev S.V., Mylnikov P.Yu., Shchulkin A.V., Yakushin S.S.
Pharmacokinetics of indapamide in patients with arterial hypertension65-72
Kurdanov Kh.A., Elbaeva A.D., Elbaev A.D., Kurdanova M.Kh.
Simulation modeling of the correlation between the components of metabolic syndrome73-83
Dugusheva V.A., Kotova Yu.A., Shevtsova V.I., Shchegoleva V.E.
Correlation between vitamin D deficiency, VDR receptor levels and apoptosis markers in comorbid patients with type 2 diabetes mellitus and arterial hypertension84-92
REVIEWS
Dzhulay G.S., Dzhulay T.E.
Female factor in the development of cholelithiasis93-99
Fairushina I.F., Akchurina O.E., Mukhametova D.D.
The role of muscle ultrasonic examination in the assessment of sarcopenia100-110
GUIDELINES FOR PRACTITIONERS
Iakovlev A.A., Volkov A.S., Bashtovaya O.A.
Efficacy and tolerability of ustekinumab in patients with ulcerative colitis after failure of first- line therapy with genetically engineered biological agents112-117
Bykova S.V., Sabelnikova E.A., Khomeriki S.G., Biryukova E.V., Zakharova A.V.
Autoimmune comorbidity: Celiac disease and type 1 diabetes mellitus118-125
Bolieva L.Z.
Chronic spontaneous (idiopathic) urticaria in combination with delayed urticaria from skin pressure126-132
LECTURE
Barysheva O.Yu., Golubeva A.M., Egorova K.E., Vezikova N.N., Varlamova D.D.
Peculiarities of the choice of therapy for inflammatory bowel diseases associated with malignant neoplasms133-139
Fominykh Yu.A., Nadzhafova K.N.
Role and clinical and pharmacological capabilities of proton pump inhibitors on the example of esomeprazole in the treatment of patients with gastrointestinal tract acid-related diseases140-152
Ketova G.G., Shamina O.M., Mironov I.L.
Rifaximine in therapy of gastrointestinal tract diseases: From the history of its creation to modern recommendations153-165
Guideline for practitioners
Alekseenko S.A., Pan A.A., Zaikova-Khelimskaya I.V.
Life quality in comorbid patients with atrial fibrillation and non-alcoholic fatty liver disease having hyperammoniemia166-172
Activities of RNMOT
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (June 2025)
174-180
